MCRB Seres Therapeutics Inc

Seres Therapeutics Inc is a microbiome therapeutics platform company which is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics.

$3.63  +0.20 (5.83%)
As of 07/01/2022 16:00:00 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  06/26/2015
Outstanding shares:  92,230,428
Average volume:  1,613,804
Market cap:   $316,350,368
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BYNQNP8
Valuation   (See tab for details)
PE ratio:   -3.86
PB ratio:   4.13
PS ratio:   2.25
Return on equity:   -107.14%
Net income %:   -61.65%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy